Hemangeol FDA Approval History
FDA Approved: Yes (First approved March 14, 2014)
Brand name: Hemangeol
Generic name: propranolol hydrochloride
Dosage form: Oral Solution
Company: Pierre Fabre Dermatologie
Treatment for: Infantile Hemangioma
Hemangeol (propranolol hydrochloride) is a pediatric beta-blocker formulation indicated for the treatment of proliferating infantile hemangioma.
Development Timeline for Hemangeol
|Mar 18, 2014||Approval Pierre Fabre Obtains FDA Approval to Market Hemangeol for the Treatment of Infantile Hemangioma|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.